Dual Egret Pharmaceuticals: Directors plan to reduce their shareholding in the company by no more than 0.0365%.

On the evening of September 17th, Shuanglu Pharmaceutical announced that Liang Shujie, a director and secretary of the board of directors holding 0.1461% of the company's shares, plans to reduce his holdings of the company's shares by a total of no more than 375,200 shares through centralized competitive bidding, with no reduction during the window period.